These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 7903213)

  • 41. [Selecting the optimal dose of a new antihypertensive agent. Its application to tertatolol].
    Amabile G; Serradimigni A; Granier J
    Ann Med Interne (Paris); 1987; 138 Suppl 1():27-30. PubMed ID: 2884913
    [No Abstract]   [Full Text] [Related]  

  • 42. Efficacy and tolerability of once-daily oral fimasartan 20 to 240 mg/d in Korean Patients with hypertension: findings from Two Phase II, randomized, double-blind, placebo-controlled studies.
    Lee H; Yang HM; Lee HY; Kim JJ; Choi DJ; Seung KB; Jeon ES; Ha JW; Rim SJ; Park JB; Shin JH; Oh BH
    Clin Ther; 2012 Jun; 34(6):1273-89. PubMed ID: 22608107
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effect of celiprolol and metoprolol on lipids, fibrinogen and airways function in hyperlipidaemic hypertensives: a randomised double-blind long-term parallel group trial.
    Johnston GD; Vyssoulis G; Feely J; Holden RD; Radley DR
    J Hum Hypertens; 1995 Feb; 9(2):123-9. PubMed ID: 7752174
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Effects of tertatolol on atherogenicity indices in normo- or dis-lipemic hypertensive patients].
    Richard JL; Jacotot B
    Ann Med Interne (Paris); 1987; 138 Suppl 1():35-8. PubMed ID: 2884915
    [No Abstract]   [Full Text] [Related]  

  • 45. Effects of carvedilol versus metoprolol on endothelial function and oxidative stress in patients with type 2 diabetes mellitus.
    Bank AJ; Kelly AS; Thelen AM; Kaiser DR; Gonzalez-Campoy JM
    Am J Hypertens; 2007 Jul; 20(7):777-83. PubMed ID: 17586413
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Reduction (TELMAR) as assessed by magnetic resonance imaging in patients with mild-to-moderate hypertension--a prospective, randomised, double-blind comparison of telmisartan with metoprolol over a period of six months rationale and study design.
    Friedrich MG; Dahlöf B; Sechtem U; Unger T; Knecht M; Dietz R;
    J Renin Angiotensin Aldosterone Syst; 2003 Dec; 4(4):234-43. PubMed ID: 14689371
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Addition of urapidil or metoprolol to the treatment of hypertensive non-responders to nifedipine monotherapy: efficacy and metabolic effects. Italian Urapidil Study Group.
    Zanchetti A
    Blood Press Suppl; 1995; 3():38-46. PubMed ID: 8535541
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Chronic effects of tertatolol on renal function in hypertensive patients with mild chronic renal failure.
    Hannedouche T; Brouard R; Godin M; Kleinknecht D; Paillard F; Grünfeld JP
    Nephrol Dial Transplant; 1991; 6(4):252-6. PubMed ID: 1679214
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effect of antihypertensive agents on plasma adiponectin levels in hypertensive patients with metabolic syndrome.
    Yilmaz MI; Sonmez A; Caglar K; Celik T; Yenicesu M; Eyileten T; Acikel C; Oguz Y; Yavuz I; Vural A
    Nephrology (Carlton); 2007 Apr; 12(2):147-53. PubMed ID: 17371337
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Circadian antihypertensive profile of carvedilol (BM 14190).
    Meyer-Sabellek W; Schulte KL; Distler A; Gotzen R
    J Cardiovasc Pharmacol; 1987; 10 Suppl 11():S119-23. PubMed ID: 2454357
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Reduction of beta-adrenergic receptors can explain the lack of rebound effect after tertatolol withdrawal.
    De Blasi A; Pittana PL; Fratelli M; Garattini S
    Am J Hypertens; 1989 Nov; 2(11 Pt 2):257S-260S. PubMed ID: 2573373
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Follow-up of a method of twenty-four-hour indirect blood pressure monitoring: evaluation of carvedilol, a new antihypertensive agent.
    Meyer-Sabellek W; Schulte KL; Distler A; Gotzen R
    Nephron; 1987; 47 Suppl 1():42-6. PubMed ID: 3320788
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Tertatolol: a beta-blocker with unique effects on human glomerular cell function.
    Shultz P; Raij L
    Cardiology; 1993; 83 Suppl 1():51-6. PubMed ID: 7903216
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Efficacy and tolerability of tertatolol in the treatment of mild to moderate arterial hypertension. Results of a French multicenter study with 2,338 patients treated over one year].
    Herpin D; Piron J; Bajou B; Lecasble M
    Ann Cardiol Angeiol (Paris); 1989 Oct; 38(8):503-7. PubMed ID: 2574560
    [No Abstract]   [Full Text] [Related]  

  • 55. Tertatolol ameliorates renal function in rats with chronic renal failure.
    Delaini F; Perico N; Tagliaferri M; Lupini C; Patino O; Remuzzi G; Garattini S
    J Pharmacol Exp Ther; 1988 Jul; 246(1):287-93. PubMed ID: 2899165
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Seven years on a selective beta-blocker - metoprolol. A long-term study of women with arterial hypertension.
    Bengtsson C
    Ann Clin Res; 1981; 13 Suppl 30():7-15. PubMed ID: 6117244
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Renal hemodynamic effects of tertatolol in essential hypertension.
    Paillard F; Lantz B; Leviel F; Ardaillou R
    Am J Nephrol; 1986; 6 Suppl 2():40-4. PubMed ID: 2879472
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Antihypertensive activity of a new vasodilator, cadralazine, administered alone or in combination with a beta-blocker.
    Buoninconti R; Motolese M
    Int J Clin Pharmacol Ther Toxicol; 1985 Nov; 23(11):613-6. PubMed ID: 2867048
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Beta-adrenergic receptor changes during tertatolol treatment in healthy volunteers: relevance for beta-blocking therapy.
    De Blasi A; Lipartiti M; Garattini S
    Am J Nephrol; 1986; 6 Suppl 2():69-73. PubMed ID: 2879475
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Once-daily metoprolol for hypertension.
    Ward MJ; Roland JM; Banks DC
    Postgrad Med J; 1981 Oct; 57(672):633-4. PubMed ID: 7038656
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.